Keyphrases
Androgens
100%
Prostate Tumor
100%
Activating Transcription Factor 3 (ATF3)
100%
Androgen Signaling
100%
Promote Apoptosis
100%
Edelfosine
100%
Androgen Deprivation Therapy
58%
Androgen Receptor
33%
LNCaP
25%
VCaP
25%
Tumor Model
8%
Human Tumors
8%
Apoptosis
8%
Antitumor Activity
8%
Promoter Activity
8%
Treatment Regimen
8%
Cell Proliferation
8%
Expression Level
8%
Negative Regulator
8%
Growth Inhibition
8%
In Vivo Experiment
8%
Small Interfering RNA (siRNA)
8%
Knockdown
8%
Transcriptional Activation
8%
Dose Effect
8%
Human Prostate Cancer Cells
8%
Tumor Volume
8%
Individual Treatment
8%
Antitumor Effect
8%
Prostate Cancer Patients
8%
Combined Treatment
8%
Stress-responsive Genes
8%
PSA Level
8%
Promoter Studies
8%
TMPRSS2-ERG Fusion
8%
Fusion Gene
8%
Receptor Transactivation
8%
Alkyl-lysophospholipid
8%
Androgen Receptor Splice Variant 7
8%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen Receptor
100%
Prostate Tumor
100%
Edelfosine
100%
Androgen
100%
Activating Transcription Factor 3
41%
Prostate Cancer
16%
Protein Kinase B
16%
Antitumor Activity
8%
Tumor Model
8%
Small Interfering RNA
8%
Alkyllysophospholipid
8%
Neoplasm
8%